- CCRN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing
Cross Country Healthcare (CCRN) 8-KOther events
Filed: 6 Nov 02, 12:00am
Cross Country Reports 3rd Quarter Results;
Revenues up 18%; Announces Share Repurchase
BOCA RATON, Fla., November 4, 2002 /PRNewswire/—Cross Country, Inc. (Nasdaq: CCRN—news) today reported revenue of $157.7 million for the three month period ended September 30, 2002, an increase of 18% over revenue of $133.5 million for the same period in the prior year. Income before discontinued operations for the third quarter of 2002 was $8.8 million or $0.26 per diluted share. Net income for the third quarter of 2002 was $5.9 million or $0.17 per diluted share, which included an after-tax loss from discontinued operations of $2.9 million, primarily reflecting asset impairment related to E-Staff's operations which have been classified as discontinued since the first quarter 2002. Earnings before interest, taxes, depreciation, amortization and non-recurring secondary offering costs (EBITDA), a key measure used by management to evaluate the company's operations, was $16.9 million for the three month period ended September 30, 2002, an increase of 4% over the same period in the prior year. The quarter was favorably impacted primarily by the results generated by the Company's travel nurse staffing businesses and lower interest and amortization expenses.
"I am pleased with Cross Country's continued generation of solid revenue and cash flow growth this quarter," said Joseph A. Boshart, Cross Country's Chief Executive Officer and President. "The underlying fundamentals driving our businesses remain strong and the demand for our nurses continue to exceed the number of nurses we have coming off contract."
For the nine month period ended September 30, 2002, Cross Country reported revenue of $468.5 million, an increase of 32% over the same period in the prior year. Net income before discontinued operations for the nine months ended September 30, 2002 was $24.4 million or $0.72 per diluted share compared to $7.6 million or $0.33 per diluted share in the same period of the prior year. Net income and its associated diluted EPS for the nine month period ended September 30, 2002 were $20.9 million and $0.62 compared to $6.6 million and $0.28, respectively, for the nine month period ended September 30, 2001. EBITDA for the nine month period ended September 30, 2002 was $48.8 million compared to $39.8 million for the same period in the prior year, an increase of 22%.
Healthcare Staffing
Cross Country's Healthcare Staffing segment, which comprises travel staffing, clinical research trials staffing and per diem staffing, generated revenue for the three month period ended September 30, 2002 of $144.9 million, an increase of 17% over the same period in the prior year. This growth was driven primarily by increased average hourly bill rates in all businesses, increased numbers of field employees in travel staffing as well as incremental revenue generated by the January 2002 acquisition of NovaPro. Contribution income, defined as earnings before interest, taxes, depreciation, amortization and corporate expenses not specifically identified to a reporting segment, for the three month period ended September 30, 2002 was $20.5 million, an increase of 4% over the same period in the prior year. This growth was primarily due to the same factors that drove revenue growth, but partially offset by an increase in recruiter compensation, increased expenses associated with recruiting nurses overseas for the Company's Assignment America business, and an increase in other selling expenses.
For the nine month period ended September 30, 2002, revenue was $431.3 million, an increase of 31% over the same period in the prior year, and contribution income was $60.0 million compared to $49.7 million for the nine month period ended September 30, 2001.
Other Human Capital Management Services
Cross Country's Other Human Capital Management Services segment, which comprises the education and training, healthcare consulting, and physician search services, generated revenue of $12.8 million for the three month period ended September 30, 2002, an increase of 36% over the same
period in the prior year. This increase was driven primarily by the double-digit increase in revenues in its consulting and seminars businesses, including the consulting business generated by the Jennings Ryan & Kolb, Inc. acquisition in March 2002. Contribution income for the three- month period ended September 30, 2002 was $1.5 million, essentially flat with the year ago period primarily due to increased marketing expenses in the Company's education businesses.
For the nine month period ended September 30, 2002, revenue was $37.2 million, an increase of 41% over the same period in the prior year and contribution income was $5.2 million compared to $4.3 million for the nine month period ended September 30, 2001.
Expectations for Fourth Quarter 2002 and Full Year 2003
The following statements are based on current management expectations. These statements are forward-looking, and actual results may differ materially. With respect to Cross Country's financial targets for the full year 2002, the Company expects revenue to be between $630 and $633 million and EPS to be $1.02 per diluted share. Fourth quarter 2002 earnings before discontinued operations are expected to be $0.28 per diluted share. With respect to Cross Country's financial targets for the full year 2003, the Company is projecting revenue to be between $730 and $765 million and EPS in the range of $1.25 to $1.30 per diluted share. These EPS targets exclude discontinued operations and expenses associated with the company's secondary offering. It is Cross Country's intention to update its guidance quarterly.
Cross Country also announced today that its Board of Directors has authorized a stock repurchase program whereby the Company may repurchase up to 1.5 million of its common shares at an aggregate price not to exceed $25 million. The shares may be repurchased from time-to-time in the open market. The repurchase program may be discontinued at any time at the discretion of the Company. Currently, the Company has approximately 32.6 million shares outstanding.
Cross Country, Inc. is a leading provider of healthcare staffing services in the United States. The company has an active client base of over 3,000 hospitals, pharmaceutical companies and other healthcare providers across all 50 states.
More information on Cross Country, Inc. can be obtained from our website,www.crosscountry.com.
A listen-only simulcast of Cross Country's third quarter conference call will be available online beginning at 10:00 a.m. EST on Tuesday, November 5th atwww.crosscountry.com,www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network such as America Online's Personal Finance Channel, Fidelity Investments® (Fidelity.com) and others. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com). A playback recording of the call may be accessed by calling 1-800-405-2236, passcode 502421#, beginning at 12:30 p.m. on November 5th until 11:59 p.m. on Wednesday, November 13th.
This release contains forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include the following our ability to attract and retain qualified nurses and other healthcare personnel, costs and availability of short-term leases for our travel nurses, demand for the healthcare services we provide, both nationally and in the regions in which we operate, the functioning of our information systems, the effect of existing or future government regulation and federal and state legislative and enforcement
2
initiatives on our business, our clients' ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, and other factors set forth under the caption "RISK FACTORS" in the Company's 10-K for the year ended December 31, 2001.
Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Given these uncertainties, the forward-looking statements discussed on this press release might not occur. While it is the Company's intention to update its guidance quarterly, it should not be assumed that our silence over time means that actual events are occurring as expressed or implied in such forward-looking statements.
For further information, please contact:
Victor Kalafa or Emil Hensel 877-686-9779
3
Cross Country, Inc.
Consolidated Statements of Operations *
(amounts in thousands, except per share data)
(Unaudited)
| Three Months Ended September 30, | | Nine Months Ended September 30, | | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % Change | % Change | ||||||||||||||||
| 2002 | 2001 | 2002 | 2001 | ||||||||||||||
Revenue from services | $ | 157,656 | $ | 133,486 | 18 | % | $ | 468,494 | $ | 356,193 | 32 | % | ||||||
Operating expenses: | ||||||||||||||||||
Direct operating expenses | 117,376 | 99,387 | 18 | % | 350,381 | 266,486 | 31 | % | ||||||||||
Selling, general and administrative expenses | 23,426 | 17,483 | 34 | % | 68,967 | 48,559 | 42 | % | ||||||||||
Bad debt expense | — | 456 | (100 | )% | 359 | 1,318 | (73 | )% | ||||||||||
Depreciation | 1,006 | 627 | 60 | % | 2,477 | 1,790 | 38 | % | ||||||||||
Amortization | 781 | 3,840 | (80 | )% | 2,336 | 11,242 | (79 | )% | ||||||||||
Non-recurring secondary offering costs | — | — | — | 1,008 | — | ND | ||||||||||||
Total operating expenses | 142,589 | 121,793 | 17 | % | 425,528 | 329,395 | 29 | % | ||||||||||
Income from operations | 15,067 | 11,693 | 29 | % | 42,966 | 26,798 | 60 | % | ||||||||||
Other expenses: | ||||||||||||||||||
Interest expense, net | 975 | 4,375 | (78 | )% | 3,131 | 12,907 | (76 | )% | ||||||||||
Income before income taxes and discontinued operations | 14,092 | 7,318 | 93 | % | 39,835 | 13,891 | 187 | % | ||||||||||
Income tax expense | (5,339 | ) | (3,221 | ) | 66 | % | (15,416 | ) | (6,260 | ) | 146 | % | ||||||
Income before discontinued operations | 8,753 | 4,097 | 114 | % | 24,419 | 7,631 | 220 | % | ||||||||||
Discontinued operations (a) | (2,881 | ) | (175 | ) | 1546 | % | (3,518 | ) | (1,035 | ) | 240 | % | ||||||
Net income | $ | 5,872 | $ | 3,922 | 50 | % | $ | 20,901 | $ | 6,596 | 217 | % | ||||||
Net income/(loss) per common share—basic: | ||||||||||||||||||
Income before discontinued operations | $ | 0.27 | $ | 0.18 | $ | 0.76 | $ | 0.33 | ||||||||||
Discontinued operations (a) | $ | (0.09 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.05 | ) | ||||||
Net income | $ | 0.18 | $ | 0.17 | $ | 0.65 | $ | 0.28 | ||||||||||
Net income/(loss) per common share—diluted: | ||||||||||||||||||
Income before discontinued operations | $ | 0.26 | $ | 0.18 | $ | 0.72 | $ | 0.33 | ||||||||||
Discontinued operations (a) | $ | (0.09 | ) | $ | (0.01 | ) | $ | (0.10 | ) | $ | (0.05 | ) | ||||||
Net income | $ | 0.17 | $ | 0.17 | $ | 0.62 | $ | 0.28 | ||||||||||
Weighted average common shares outstanding — basic | 32,572 | 23,206 | 32,402 | 23,206 | ||||||||||||||
Weighted average common shares outstanding — diluted | 33,615 | 23,206 | 33,871 | 23,206 |
ND—Not determinable
4
Cross Country, Inc.
Consolidated Condensed Balance Sheets *
(amounts in thousands)
| September 30, 2002 | December 31, 2001 | |||||
---|---|---|---|---|---|---|---|
| (Unaudited) | | |||||
Current assets: | |||||||
Cash | $ | 30,143 | $ | 2,736 | |||
Accounts receivable, net | 91,301 | 87,415 | |||||
Assets from discontinued operations, net | 303 | 3,483 | |||||
Other current assets | 14,513 | 14,996 | |||||
Total current assets | 136,260 | 108,630 | |||||
Property and equipment, net | 12,144 | 8,502 | |||||
Goodwill, net | 226,018 | 218,749 | |||||
Trademark, net | 15,749 | 15,399 | |||||
Other identifiable intangible assets, net | 7,783 | 9,308 | |||||
Other assets | 1,202 | 1,392 | |||||
Total assets | $ | 399,156 | $ | 361,980 | |||
Current liabilities: | |||||||
Accounts payable and accrued expenses | $ | 3,450 | $ | 3,172 | |||
Accrued employee compensation and benefits | 30,786 | 26,930 | |||||
Current portion of debt | 13,248 | 3,790 | |||||
Income taxes payable | 8,569 | — | |||||
Liabilities from discontinued operations | 169 | 174 | |||||
Other current liabilities | 2,739 | 1,832 | |||||
Total current liabilities | 58,961 | 35,898 | |||||
Interest rate swap | 1,151 | 2,509 | |||||
Deferred income taxes | 9,102 | 8,570 | |||||
Long-term debt | 32,047 | 45,076 | |||||
Total liabilities | 101,261 | 92,053 | |||||
Commitments and contingencies | |||||||
Stockholders' equity: | |||||||
Common stock | 3 | 3 | |||||
Additional paid-in capital | 264,366 | 258,152 | |||||
Other stockholders' equity | 33,526 | 11,772 | |||||
Total stockholders' equity | 297,895 | 269,927 | |||||
Total liabilities and stockholders' equity | $ | 399,156 | $ | 361,980 | |||
5
Segment Data*
(amounts in thousands)
(Unaudited)
| Three Months Ended September 30, | | Nine Months Ended September 30, | | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % Change | % Change | ||||||||||||||||
| 2002 | 2001 | 2002 | 2001 | ||||||||||||||
Revenues: | ||||||||||||||||||
Healthcare staffing | $ | 144,861 | $ | 124,096 | 17 | % | $ | 431,262 | $ | 329,849 | 31 | % | ||||||
Other human capital management services | 12,795 | 9,390 | 36 | % | 37,232 | 26,344 | 41 | % | ||||||||||
$ | 157,656 | $ | 133,486 | 18 | % | $ | 468,494 | $ | 356,193 | 32 | % | |||||||
Contribution income (a): | ||||||||||||||||||
Healthcare staffing | $ | 20,531 | $ | 19,663 | 4 | % | $ | 59,983 | $ | 49,746 | 21 | % | ||||||
Other human capital management services | 1,471 | 1,470 | 0 | % | 5,154 | 4,256 | 21 | % | ||||||||||
Unallocated corporate overhead | (5,148 | ) | (4,973 | ) | 4 | % | (16,350 | ) | (14,172 | ) | 15 | % | ||||||
EBITDA (b) | $ | 16,854 | $ | 16,160 | 4 | % | $ | 48,787 | $ | 39,830 | 22 | % | ||||||
Financial Statistics
(Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2002 | 2001 | 2002 | 2001 | |||||||||
EBITDA — ($000) (b) | $ | 16,854 | $ | 16,160 | $ | 48,787 | $ | 39,830 | |||||
EBITDA as % of revenue | 10.7 | % | 12.1 | % | 10.4 | % | 11.2 | % | |||||
FTE's (c) | 5,448 | 4,953 | 5,536 | 4,657 | |||||||||
Weeks worked (d) | 70,824 | 64,389 | 215,904 | 181,623 | |||||||||
Average healthcare staffing revenue per FTE per week (e) | 2,045 | 1,927 | 1,997 | 1,816 |
6